Skip to main content
The Application of Clinical Genetics logoLink to The Application of Clinical Genetics
. 2012 Apr 14;3:29–39. doi: 10.2147/tacg.s8794

Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects

Fabricio González-Andrade 1,, Ramiro López-Pulles 2
PMCID: PMC3681162  PMID: 23776361

Abstract

Aim

This study sets out (a) to estimate the prevalence of admissions by birth defects, using the official database of hospitals of Ecuador; and (b) to set the basis for a new National Register of Birth Defects in Ecuador that works as a program for the clinical and epidemiological investigation of risk factors in the etiology of congenital anomalies in Ecuadorian hospitals, using a case-control methodological approach. This is the first report in their class.

Methods

The data used in this study are derived from the National Register of Hospital Admission/Discharges of the Instituto Nacional de Estadísticas y Censos; data of the Ministry of Public Health were also used. Ecuador does not have an official Medical Birth Registry or a Congenital Malformations Registry.

Results

A total of 51,375 discharges by congenital malformations were registered in a 7-year period. Of these, 16,679 admissions were of children aged less than 1 year of age, with a birth prevalence rate (BPR) of 72.33/10,000 births. 77% of the congenital defects registered comprise the 50 most common birth defects observed in this age group. Cleft lip was the most prevalent birth defect in children less than 1 year of age and the second most common defect in children 1 to 5 years of age. Unilateral cleft lip shows a BPR of 4.57/10,000 births; cardiac birth defects as a group have a BPR of 4.2; hydrocephalus a BPR of 3.77; and Down’s syndrome a BPR of 3.70. Undescended testicle was the most prevalent birth defect in children between 1 to 5 years. 9384 children under 1 year of age were male (55.9%) and 7053 were female (42.1%). BPR in males was 40.45 and in females 30.40.

Conclusion

This report documents the prevalence estimates for birth defects reported in the hospital discharge data. These estimates are important to 1) plan for health-care and education needs of the Ecuadorian population, 2) identify increased occurrences of birth defects in specific geographic regions, 3) serve as a reference point for assessment of provincial surveillance systems, 4) evaluate national public health interventions, 5) compare Ecuador prevalence estimates with those of other countries, and 6) help determine the appropriate allocation of resources for basic and public health research. There is an urgent need to establish a National Registry of Birth Defects involving different sources of information such as prenatal medical records, birth records and medical records during the first year of life at an early stage, and surveys on cytogenetic prenatal diagnostic surveys and cytogenetics of therapeutic abortions.

Keywords: Ecuador, genetics, birth defects surveillance, database, prevalence, epidemiology, congenital malformations

Introduction

This study sets out (a) to estimate the prevalence of admissions by birth defects, using the database of hospitals of Ecuador; and (b) to set the basis for a new National Register of Birth Defects in Ecuador that works as a program for the clinical and epidemiological investigation of risk factors in the etiology of congenital anomalies in Ecuadorian hospitals, using a case-control methodological approach. This is the first report in their class.

There is a lack of information on population-based studies of malformations in Ecuador;1 the surveillance of the effects of prenatal screening and diagnosis on the birth prevalence of malformations is limited by gaps and wide variations in surveillance systems.2 This justifies the use of official databases in the production of the information only as an initial step in the development of an organized and generalized system that gathers in an organized way birth defects data, as proposed in this paper.

The only official existing data are limited to a few hospitals, such as those that are part of the ECLAMC network (Latin American Collaborative Study on Congenital Malformations).3 This network was established in 1973, originally with 12 maternity hospitals in 6 provinces around the country, covering approximately 4.16% of the total number of live births in Ecuador. This network reported 1.7% of newborns (1,114/66,843) and 1.3% of stillbirths (891/66,843) with some type of congenital malformation, in a study made between June 2001 and June 2005.4 The hospitals associated with this network are mostly secondary care hospitals located in the cities of Quito, Manta, Chone, Bahía de Caráquez, Portoviejo, Cañar, Azogues, Ibarra, Loja and Machala.5 Despite the importance of this network, this study did not cover the whole country because participation is still voluntary, which limits coverage to less of 5% of all live births in Ecuador. However, morbidity studies of children indicated that genetic diseases and congenital malformations represent 10% to 25% of hospitalizations in tertiary care facilities, especially in some Latin America cities.6,7

Ecuador has a relatively small but genetically highly diverse population across the whole country. There is a need for a central coordination of information on availability of prenatal diagnosis, newborn screening, and genetic testing with modern genetic technologies. It should be stressed that demographic factors also have a great influence on the prevalence of some congenital malformations.8 In this regard, it should be noted that Ecuador is located in western South America,9 where half the population lives in cities with altitudes of 2000 m asl.10 The population is 14 million, approximately half (54%) of whom live in urban zones, especially in the four largest cities of Quito, Guayaquil, Cuenca and Santo Domingo.11 Ecuador is a multi-ethnic country with a strong Native Amerindian culture12 that coexists with Mestizo and Afroamerican ethnic groups.

Childbearing-age women in Ecuador are potentially exposed to high teratogenic risks such as infectious agents, environmental chemical compounds, radiation, drugs, and maternal metabolic diseases.13 These risk factors interact with the low levels of school education and low socioeconomic status of the population, and scarce resources in the public health care system for the prevention and treatment of congenital anomalies.14 The birth prevalence of congenital anomalies in developing countries is underestimated, mainly due to deficiencies in diagnostic capabilities and lack of reliability of medical records and health statistics.8 The recorded rates in developing countries must be considered minimum estimates because of low diagnostic capacities and underreporting.8

According to the health authorities of the United States,15 birth defects are a significant public health concern, affecting ~3% of all births, and resulting in many elective pregnancy terminations or spontaneous abortions, a situation similar to that seen in Europe, where birth defects affect ~2% of all births.16 Every year, ~150,000 babies are born with birth defects in developed countries.17 Birth defects and genetic diseases are the leading causes of infant deaths, resulting in substantial mortality and morbidity throughout childhood.18 Although birth defects account for only 15% to 30% of all pediatric hospitalizations in developed countries, they have a proportionally higher cost in health care programs than other hospitalizations.19 In the US, US$8 billion are spent each year to provide medical and rehabilitative care for affected children. Thus, birth defects impart a significant burden to families and society.20

The causes of around 40% to 50% of birth defects are unknown,21 20% are attributed to a combination of hereditary and environmental factors, 8% to 10% to single-gene mutations, 6% to chromosome abnormalities, and 5% to maternal illnesses.21 There is also an important increase in birth defects and developmental disabilities due to maternal conditions.22 These maternal conditions comprise pregestational diabetes and phenylketonuria, and other related pathologies. Maternal diabetes mellitus is associated with increased teratogenesis, which can occur in pre-gestational diabetes type 1 and type 2. Cardiac defects and neural tube defects are the most common malformations observed in fetuses of pre-gestational mothers with diabetes.23

Certain infections, such as rubella virus (which causes German measles and congenital rubella syndrome) and cytomegalovirus (which causes a congenital infection that also produces birth defects and developmental disabilities), have shown to be highly teratogenic.24 Equally, some medications as valproic acid and isotretionin have shown teratogenic effects. The most teratogenic anti-epileptic drug seems to be valproic acid which causes about 2% of neural tube diseases and an additional increase of 4% to 8% in major congenital anomalies.25 In this description, lifestyle factors such as alcohol consumption and smoking are also considered as teratogenic. Alcohol causes fetal alcohol syndrome and other spectrum disorders, for which strong prevention strategies have been developed.26 All of the above-mentioned causes are preventable risk factors.27

Material and methods

Design

This is an observational descriptive study that evaluates the epidemiological issues of birth defects reported in Ecuador between the years of 2001 and 2007.

Source of information

The data used in this study were taken from the National Register of Hospital Admission/Discharges of the Instituto Nacional de Estadísticas y Censos (INEC),17 and the Ministry of Public Health (MSP).28 The Register of Admissions/ Discharges is national and funded by the government. The information from the register is provided primarily by the centers and hospitals belonging to the MSP which has a national coverage and includes public maternity clinics, children’s hospitals, and general adult hospitals. The information in this register was gathered from the individual clinic history, by a clerk who codes the diagnosis. This register has been, formerly and extensively, used in epidemiological studies.8 Ecuador does not have an official Medical Birth Registry or a Congenital Malformations Registry.

Study variables

Major congenital malformation was defined as a defect detected at birth, delivery or during the first year of life, which results in death (including still birth); it requires major surgery, or has a major effect on the quality of life for the child. In this study, we used the International Classification of Diseases, 10th Edition of 1997 (ICD-10) to classify the Congenital Malformations, Deformations, and Chromosomal Abnormalities, all included in the Q00 to Q99 codes.29 The data of two main groups of children, under the age of 1 year, and 1 to 5 years of age, were analyzed. All remaining age groups were excluded because it could not be identified if the patient was to be admitted by walk-ins or subsequent appointment. As an additional measure, duplicate records were excluded from the database and whether each patient was registered only once was reviewed, for the readmissions registry.

Statistical analysis

We analyzed birth prevalence rate (BPR) by 10,000 births. We also used data on admissions/discharges of children under 1 year of age who were admitted by birth defects or other previously acquired related complications.

Results

A total of 51,375 discharges by congenital malformations were registered in Ecuador, during the 7-year period analyzed, for all age groups. Out of the total, 16,679 admissions were of children less than 1 year of age, and with a BPR of 72.33/10,000 births. Seventy-seven percent of these comprised the 50 most common birth defects observed in this age group (see Table 1). The most common birth defect found is the unilateral cleft lip with a BPR of 4.57/10,000 births, followed by congenital heart malformations with a BPR 4.2; hydrocephalus with a BPR of 3.77 and Down’s syndrome with a BPR of 3.70. 9384 children under 1 year of age were male (55.9%) and 7053 were female (42.1%). The BPR of males was 40.45 and of females 30.40.

Table 1.

The most common birth defects in children under 1 year of age admitted to Ecuadorian hospitals

Rank Code Description 2001 2002 2003 2004 2005 2006 2007 Total % BPR
1 Q369 Cleft lip, unilateral 208 195 137 112 143 138 126 1059 6.35 4.57
2 Q249 Congenital malformation of heart, unspecified 131 119 143 177 139 132 135 976 5.85 4.21
3 Q039 Hydrocephalus 113 0 163 130 173 135 161 875 5.25 3.77
4 Q909 Down’s syndrome 109 137 127 127 122 134 102 858 5.14 3.70
5 Q250 Patent ductus arteriosus 68 95 55 69 68 95 57 507 3.04 2.19
6 Q059 Spina bifida, unspecified 88 117 64 53 66 55 54 497 2.98 2.14
7 Q359 Cleft palate, unilateral 71 64 71 54 45 67 70 442 2.65 1.91
8 Q400 Congenital hypertrophic pyloric stenosis 62 66 36 53 66 61 64 408 2.45 1.76
9 Q750 Craniosynostosis 38 34 40 78 62 61 90 403 2.42 1.74
10 Q899 Congenital malformation, unspecified 39 24 59 113 68 70 24 397 2.38 1.71
11 Q205 Discordant atrioventricular connection 95 108 37 38 33 30 49 390 2.34 1.68
12 Q379 Unspecified cleft palate with unilateral cleft lip 39 56 51 57 71 61 31 366 2.19 1.58
13 Q423 Imperforate anus 47 58 38 37 24 41 40 285 1.71 1.23
14 Q539 Undescended testicle, unspecified 33 26 37 29 57 59 39 280 1.68 1.21
15 Q170 Microtia 6 26 32 51 40 50 71 276 1.65 1.19
16 Q439 Congenital malformation of intestine, unspecified 32 39 38 38 38 46 42 273 1.64 1.18
17 Q663 Other congenital varus deformities of feet 60 32 30 27 31 41 51 272 1.63 1.17
18 Q699 Polydactyly, unspecified 39 39 27 31 40 46 36 258 1.55 1.11
19 Q652 Congenital luxation of the hip 21 42 37 36 22 29 37 224 1.34 0.97
20 Q390 Atresia of esophagus without fistula 26 43 25 25 36 33 27 215 1.29 0.93
21 Q212 Atrioventricular septal defect 10 15 18 20 27 82 33 205 1.23 0.88
22 Q999 Chromosomal abnormality, unspecified 11 16 9 33 30 103 3 205 1.23 0.88
23 Q043 Other reduction deformities of brain 8 38 35 32 37 22 25 197 1.18 0.85
24 Q381 Ankyloglossia 20 15 21 25 19 34 53 187 1.12 0.81
25 Q793 Gastroschisis 9 14 32 29 29 43 26 182 1.09 0.78
26 Q248 Other specified congenital malformations of heart 15 33 24 13 11 65 9 170 1.02 0.73
27 Q668 Clubfoot NOS (not otherwise specified) 24 19 21 26 32 20 21 163 0.98 0.70
28 Q213 Tetralogy of Fallot 17 32 16 9 29 25 21 149 0.89 0.64
29 Q658 Other congenital deformities of hip 17 22 15 31 12 32 16 145 0.87 0.63
30 Q419 Congenital absence, atresia and stenosis of small intestine, part unspecified 13 21 29 17 25 27 12 144 0.86 0.62
31 Q211 Atrial septal defect 0 12 10 23 24 34 35 138 0.83 0.59
32 Q02 Microcephaly 6 14 22 28 16 16 36 138 0.83 0.59
33 Q660 Talipes equinovarus 10 25 19 11 18 9 36 128 0.77 0.55
34 Q019 Encephalocele 7 15 14 14 14 29 18 111 0.67 0.48
35 Q790 Congenital diaphragmatic hernia 15 10 16 13 20 13 22 109 0.65 0.47
36 Q410 Congenital absence, atresia and stenosis of duodenum 13 11 12 9 15 17 27 104 0.62 0.45
37 Q203 Transposition of great vessels 18 17 12 12 10 19 11 99 0.59 0.43
38 Q212 Atrioventricular septal defect 0 23 10 16 14 17 16 96 0.58 0.41
39 Q897 Multiple congenital malformations, not elsewhere classified 11 12 15 18 9 20 9 94 0.56 0.41
40 Q031 Atresia of foramina of Magendie and Luschka 33 21 12 15 0 7 0 88 0.53 0.38
41 Q792 Exomphalos 9 12 15 11 13 17 11 88 0.53 0.38
42 Q228 Other congenital malformations of tricuspid valve 10 13 25 10 13 11 5 87 0.52 0.38
43 Q431 Hirschsprung’s disease 17 9 15 7 10 11 16 85 0.51 0.37
44 Q620 Congenital hydronephrosis 7 15 17 14 21 9 83 0.50 0.36
45 Q054 Unspecified spina bifida with hydrocephalus 15 14 13 8 13 3 15 81 0.49 0.35
46 Q000 Anencephaly 10 11 12 14 17 8 8 80 0.48 0.34
47 Q378 Unspecified cleft palate with bilateral cleft lip 7 8 19 13 7 11 7 72 0.43 0.31
48 Q224 Congenital tricuspid stenosis 16 11 10 8 13 7 6 71 0.43 0.31
49 Q223 Other congenital malformations of pulmonary valve 2 0 0 0 19 44 2 67 0.40 0.29
50 Q255 Atresia of pulmonary artery 12 13 11 8 6 8 7 65 0.39 0.28

Subtotal 1687 1811 1729 1825 1860 2159 1821 12892 77 55.58
Remain birth defects 460 702 511 442 624 605 543 3887 23 16.76
Overall 2147 2513 2240 2267 2484 2764 2364 16779 100 72.33

Notes: BPR = birth prevalence rate calculated with 2,319,737 births in the 7 years analyzed; BPR by 10,000 total births.

In Ecuador, every year 7339 children are admitted with a birth defect or other previously acquired complications; 18 patients out of every 10,000 hospitalizations are admitted with a congenital defect. Cardiac defects are the main reason for hospitalization and cleft lip is the most prevalent birth defect. Microtia and anotia show the highest prevalence in Latin America, according to the ECLAMC data.4 One percent of all deaths are from congenital malformations and 36% of these were mainly due to cardiac congenital defects.

Table 2 shows the birth defects in children 1 to 5 years of age. In this group the most common birth defect was undescended testicle with a BPR of 9.36/10,000 births, followed by unilateral cleft palate with a BPR of 5.32, patent ductus arteriosus with a BPR of 2.97 and unilateral cleft palate with a BPR of 2.72. This table reports 14,495 discharges in this particular group. Both analyzed groups comprise 60.7% (31,174 admissions) of total admissions. The overall BPR of birth defects in children under 1 year is 55.58/10,000 births and in children between 1 and 5 years is 50.33/10,000 births.

Table 2.

The most common birth defects in children 1 to 5 years of age that were admitted to Ecuadorian hospitals

Rank Code Description 2001 2002 2003 2004 2005 2006 2007 Total % BPR
1 Q539 Undescended testicle, unspecified 352 320 240 293 288 339 339 2171 14.98 9.36
2 Q359 Cleft palate, unilateral 188 223 173 167 141 184 159 1235 8.52 5.32
3 Q250 Patent ductus arteriosus 92 116 75 102 94 88 121 688 4.75 2.97
4 Q369 Cleft lip, unilateral 120 114 68 82 97 78 73 632 4.36 2.72
5 Q381 Ankyloglossia 46 63 64 61 62 90 121 507 3.50 2.19
6 Q652 Congenital luxation of the hip 76 50 71 84 45 52 71 449 3.10 1.94
7 Q205 Discordant atrioventricular connection 63 106 56 44 36 43 52 400 2.76 1.72
8 Q039 Congenital hydrocephalus 63 0 64 53 43 77 76 376 2.59 1.62
9 Q658 Other congenital deformities of hip 18 28 22 25 33 72 68 266 1.84 1.15
10 Q249 Congenital malformation of heart, unspecified 33 30 39 36 41 30 49 258 1.78 1.11
11 Q660 Talipes equinovarus 9 51 53 26 24 34 55 252 1.74 1.09
12 Q379 Unspecified cleft palate with unilateral cleft lip 32 35 41 32 33 49 28 250 1.72 1.08
13 Q213 Tetralogy of Fallot 30 54 42 25 17 28 52 248 1.71 1.07
14 Q549 Hypospadias 38 50 24 32 22 39 40 245 1.69 1.06
15 Q699 Polydactily 41 33 27 27 40 44 28 240 1.66 1.03
16 Q663 Other congenital varus deformities of feet 26 21 31 37 35 19 35 204 1.41 0.88
17 Q892 Persistent thyroglossal duct, thyroglossal cyst 39 32 26 22 21 25 38 203 1.40 0.88
18 Q668 Deformities of feet: clubfoot, hammer toe, congenital talipes 30 36 14 30 28 36 22 196 1.35 0.84
19 Q909 Down’s syndrome 21 35 26 36 28 21 27 194 1.34 0.84
20 Q750 Craniosynostosis 18 24 29 28 28 26 24 177 1.22 0.76
21 Q210 Ventricular septal defect 12 16 16 26 14 30 36 150 1.03 0.65
22 Q899 Congenital malformation, unspecified 5 0 31 67 12 24 8 147 1.01 0.63
23 Q439 Congenital malformation of intestine, unspecified 14 21 19 28 17 23 20 142 0.98 0.61
24 Q043 Other reduction deformities of brain 7 77 9 7 10 12 8 130 0.90 0.56
25 Q552 Other congenital malformations of testis and scrotum 27 15 17 13 10 19 29 130 0.90 0.56
26 Q431 Hirschsprung’s disease 18 24 19 14 17 18 11 121 0.83 0.52
27 Q02 Microcephaly 14 10 14 23 15 28 17 121 0.83 0.52
28 Q709 Syndactyly 20 18 17 10 15 19 18 117 0.81 0.50
29 Q211 Atrial septal defect 7 13 12 14 9 18 39 112 0.77 0.48
30 Q532 Undescended testicle, bilateral 17 7 11 4 15 16 34 104 0.72 0.45
31 Q531 Undescended testicle, unilateral 0 0 1 1 1 10 86 99 0.68 0.43
32 Q740 Other congenital malformations of limb(s) 9 8 16 12 20 11 15 91 0.63 0.39
33 Q100 Congenital blepharoptosis 9 8 8 14 21 15 15 90 0.62 0.39
34 Q556 Other congenital malformations of penis 5 3 3 23 35 7 5 81 0.56 0.35
35 Q423 Imperforate anus 22 13 11 3 8 12 9 78 0.54 0.34
36 Q181 Preauricular sinus and cyst 3 12 9 13 8 6 13 64 0.44 0.28
37 Q059 Spina bifida, unspecified 8 16 8 5 13 0 12 62 0.43 0.27
38 Q643 Other atresia and stenosis of urethra and bladder neck 10 23 6 5 1 5 11 61 0.42 0.26
39 Q393 Congenital stenosis and stricture of esophagus 15 7 6 5 8 10 6 57 0.39 0.25
40 Q620 Congenital hydronephrosis 3 5 5 7 8 11 16 55 0.38 0.24
41 Q204 Double inlet ventricle 12 8 6 4 6 12 6 54 0.37 0.23
42 Q430 Meckel’s diverticulum 6 12 3 5 10 11 7 54 0.37 0.23
43 Q212 Atrioventricular septal defect 10 8 7 5 5 4 10 49 0.34 0.21
44 Q172 Microtia 4 1 10 8 8 4 13 48 0.33 0.21
45 Q251 Coarctation of aorta 4 8 3 3 5 9 16 48 0.33 0.21
46 Q541 Hypospadias 1 10 13 6 3 5 9 47 0.32 0.20
47 Q692 Accessory toe(s) 7 5 12 4 4 4 9 45 0.31 0.19
48 Q378 Unspecified cleft palate with bilateral cleft lip 2 4 14 8 5 3 7 43 0.30 0.19
49 Q540 Hypospadias, balanic 3 8 3 6 7 6 10 43 0.30 0.19
50 Q255 Atresia of pulmonary artery 5 6 10 1 4 8 8 42 0.29 0.18

Subtotal 1614 1787 1504 1586 1470 1734 1981 11676 80.5 50.33
Remain birth defects 355 328 353 339 474 463 507 2819 19.5 12.15
Overall 1969 2115 1857 1925 1944 2197 2488 14495 100 62.49

Notes: BPR = birth prevalence rate calculated with 2,319,737 births in the 7 years analyzed.

Table 3 compares prevalence rates by country and network; our prevalence rates are significantly lower than those of each country analyzed. Table 4 shows the major congenital malformations reported by the ECLAMC Network, a rate calculated as 66,843 births out of 12 hospitals in this network.

Table 3.

Comparison of prevalence rates by country and network41

Country Latin-America Cuba Costa Rica Mexico Spain Finland Texas Ecuador Ecuador
Network ECLAMC RECUMAC CREC RYVEMCE ECEMC CREC BDES ECLAMC Our data*
Year 2005 2005 2005 2005 2005 2005 2004 2005 2009
Total births 192,882 117,923 71,548 29,463 106,728 57,927 383,192 66,843 2,319,737
Anencephaly 5.08 2.46 1.26 2.72 0.19 3.11 2.24 3.1 0.34
Spina bifida 8.71 5.43 2.80 4.75 1.50 5.01 4.49 4.2 2.49
Encephalocele 2.64 1.36 0.56 1.02 0.28 2.07 0.55 0.9 0.48
Microcephaly 3.94 0.93 1.68 3.05 1.03 1.73 8.72 1.9 0.59
Holoprosencephaly 1.56 0.76 0.00 2.72 0.47 1.73 0.99 nr 0.04
Hydrocephaly 14.78 8.90 1.26 7.47 1.97 5.18 6.03 5.5 3.77
Anophthalmos 2.70 0.17 0.00 1.36 0.09 0.35 0.29 nr nr
Microphthalmos 1.30 0.17 0.70 nr 1.41 1.21 2.30 nr nr
Anophthalmos/microphthalmos 0.00 0.08 0.00 nr 0.00 0.00 0.00 2.1 nr
Anotia 0.41 0.08 0.00 9.16 0.00 nr 0.31 nr nr
Microtia 6.95 0.25 1.96 nr 1.31 nr 3.00 10.8 1.19
Unspecified anotia/microtia 0.10 0.25 0.00 nr 0.00 4.66 0.00 nr nr
Transposition of great vessels 0.62 2.37 0.14 0.68 1.22 3.63 4.36 2.1 0.43
Tetralogy of Fallot 1.24 1.53 1.12 0.00 0.75 4.66 2.66 nr 0.64
Hypoplastic left heart syndrome 1.04 1.53 0.14 0.00 0.28 4.49 2.01 0.3 nr
Coarctation of aorta 0.31 1.10 0.28 0.00 0.75 8.11 4.38 nr 0.19
Choanal atresia, bilateral 0.21 0.00 0.28 0.00 0.09 1.04 0.73 nr 0.17
Cleft palate without cleft lip 5.86 2.37 2.38 3.05 4.12 14.33 5.09 4.2 1.91
Cleft lip with or without cleft palate 14.52 4.66 6.01 12.56 3.09 11.05 11.46 18 3.24
Esophageal atresia/stenosis with or without fistula 3.37 2.37 2.38 2.72 1.87 3.80 1.57 2.8 0.93
Small intestine atresia/stenosis 3.99 1.87 0.98 2.38 0.37 0.86 1.72 0.9 0.62
Anorectal atresia/stenosis 5.81 0.93 3.77 4.41 1.97 4.66 4.33 3.9 1.23
Undescended testis 7.05 3.48 8.39 nr 2.44 nr 10.52 nr 1.21
Hypospadias 4.15 10.18 4.89 5.77 1.31 12.08 16.26 2.5 0.18
Epispadias 0.05 0.34 0.14 0.34 0.19 2.76 0.65 nr nr
Indeterminate sex 2.49 0.51 1.82 2.72 0.66 0.00 0.81 nr 0.08
Renal agenesis 2.64 0.85 1.12 1.02 0.19 1.55 1.91 nr 0.05
Cystic kidney 3.27 2.80 0.28 0.68 1.78 1.90 5.30 2.2 0.31
Bladder exstrophy 0.21 0.17 0.00 0.34 0.09 7.60 0.29 nr 0.03
Polydactyly, preaxial 4.25 0.85 9.50 11.20 3.19 0.69 3.00 3 1.11
Diaphragmatic hernia 3.63 2.46 2.80 1.36 1.03 0.00 2.56 1.6 0.47
Omphalocele 4.51 2.37 1.54 2.04 0.84 3.80 2.04 1.3 0.38
Gastroschisis 5.18 3.31 1.12 5.77 0.09 5.35 4.18 0.1 0.78
Prune belly sequence 0.73 0.08 0.56 0.68 0.09 0.17 0.31 nr nr
Trisomy 13 0.67 1.19 1.12 0.00 0.47 0.35 1.17 nr nr
Trisomy 18 1.71 1.36 1.82 0.00 0.47 1.38 2.45 nr 0.05
Down’s syndrome, all ages 18.51 10.94 8.11 11.20 7.40 7.60 12.81 13.6 3.70
*

Our data are from the national Registry of Admission/Discharge, source INEC.11 It analyzed the data from children under 1 year of age.

Abbreviations: ECLAMC, Latin American Collaborative Study of Congenital Malformations; RECUMAC, Cuban Register of Congenital Malformation; RYVEMCE, Mexican Registry and Epidemiological Surveillance of External Congenital Malformations; ECEMC, Spanish Collaborative Study of Congenital Malformations; BDES, Texas Birth Defects Epidemiology and Surveillance Branch; CREC, Costa Rican Birth Defects Register Center.41

Table 4.

Major congenital malformations in Ecuador reported by the ECLAMC Network4

Malformation N = Rate ICD-10 ICD-8 Rank
Cleft lip 120 18 Q35 749A 1
Down’s syndrome 91 13.6 Q90 7593 2
Postaxial polidactily 90 13.5 Q69 7550 3
Talipes equinovarus 73 10.9 Q66 7541 4
Microtia/anotia 72 10.8 Q17 745A 5
Subluxation of hip 72 10.8 Q65 7556 6
Hydrocephaly 37 5.5 Q03 7420 7
Bifid spine 28 4.2 Q05 741 8
Cleft palate 28 4.2 Q36 7490 9
Imperforate anus 26 3.9 Q42 7512 10
Anencephaly 21 3.1 Q00 7400 11
Septal defects 20 3.0 Q21 746SE 12
Preaxial polidactily 20 3.0 Q69 7550B 13
Esophageal atresia 19 2.8 Q39 7502 14
Syndactyly 18 2.7 Q70 7551R 15
Hypospadias 17 2.5 Q54 7522 16
Limb agenesia (amputation) 17 2.1 Q74 755/2 17
Polycystic kidney 15 2.2 Q61 7531 18
Trunk conal defect 14 2.1 Q21 746TO 19
Anophthalmos/microphthalmos 14 2.1 Q11 744 20
Talipes talovalgus 13 1.9 Q66 7542 21
Microcephaly 13 1.9 Q02 7431 22
Congenital hydronephrosis 12 1.8 Q62 7532 23
Diaphragmatic hernia 11 1.6 Q79 75681 24
Other cardiopathies 10 1.5 Q20 746 25

Notes: BPR calculated from 66,843 lives births in 12 hospitals of the network.

Abbreviations: ICD, International Classification of Diseases 10th Edition and 8th Edition.29

Birth defects caused 1% of all deaths in Ecuador during the period analyzed. Cardiac malformations (35.95% of all cases) were the highest cause of birth defect mortality, followed by congenital malformations (10.66%). Congenital malformations of spleen, adrenal gland, parathyroid or thyroid gland, persistent thyroglossal duct and cyst, and the situs inversus comprised the other unclassified causes (Table 5).

Table 5.

General mortality rates by birth defects in Ecuador

Year N = PMR Mortality rate
2001 580 1.050 0.045
2002 510 0.918 0.039
2003 480 0.897 0.037
2004 503 0.919 0.039
2005 555 0.977 0.042
2006 617 1.065 0.046
2007 678 1.169 0.050
Total 3923 1.001 0.043
ICD-10 N = %
Q24: Dextrocardia, levocardia, cor triatriatum, pulmonary infundibular stenosis, congenital subaortic stenosis, malformation of coronary vessels, congenital heart block, others 919 23.43
Q89: Congenital malformations of spleen, of adrenal gland, other endocrine glands; situs inversus; conjoined twins; multiple congenital malformations 418 10.66
Q03: Congenital hydrocephalus 271 6.91
Q01: Anencephaly and similar malformations 204 5.20
Q21: Congenital malformations of cardiac septa 204 5.20
Q25: Congenital malformations of great arteries 172 4.38
Q90: Down’s syndrome, trisomy 21 157 4.00
Q20: Congenital malformations of cardiac chambers and connections 115 2.93
Q79: Congenital diaphragmatic hernia, exomphalos, gastroschisis, prune belly syndrome, others 112 2.85
Q87: Multisystemic birth defects, congenital syndromes 110 2.80
Subtotal 1763 68.37
Others birth defects 2160 31.63
Overall 3923 100.00
Q20 + Q21 + Q24 + Q25 (all cardiac birth defects) 1410 35.94

Source: INEC.11

Abbreviation: PMR, proportionate mortality rate.

Discussion

Birth defects

The overall prevalence at birth of the selected congenital defects in Ecuador was 72.3/10,000 births. This result is significantly lower than in the registries of other countries mainly due to under-reporting and the low quality of Ecuador’s surveillance system. These figures should be taken as minimal estimates with uncertain diagnostic accuracy because Ecuador does not have an official medical birth registry or a congenital malformations registry.

However, in Ecuador the low level of education and cultural misconceptions have led many families to hide birth defects because their reporting could lead to the families being stigmatized by their social group, mainly in isolated rural populations.30 There is limited knowledge of genetics and its terminology in the general population. Shamanic and marginal health practices seem to remain prevalent especially in rural communities due to the lower costs and the lack of access to health care, the personal attention the individuals receive, and the holistic point of view used.31 Furthermore, there has been an increase in teenage pregnancies in recent years in Ecuador, aggravated by the major risk factors such as low family income, poor education, lack of knowledge about reproductive health and poor psychological family support. Adverse outcomes in mothers, such as high rates of cesarean section, puerperal infections, and complication during childbirth, have been identified; and adverse outcomes also in the fetus, such as premature birth, low birth weight and small size for gestational age have been identified also. All of these contribute to the numbers of birth defects.32

Because we found a massive under-reporting of birth defects in the Admissions/Discharge Registries, they are not a reliable single source for ascertaining congenital malformations. However, their availability allowed us to perform a natural experiment to assess our registration system and identify weaknesses in data collection. Our findings agreed with those of Penchaszadeh13 who noted that the birth prevalence of congenital anomalies in the developing world is underestimated by deficiencies in diagnostic capabilities and lack of reliability of medical records and health statistics. As a result, recorded diagnoses in statistics focus on overt acute illnesses, rather than on pre-existing congenital conditions that increase vulnerability to infections and malnutrition.

Cleft lip was the most prevalent birth defect in children under 1 year of age, and the second most common defect in children of 1 to 5 years of age. This finding seems similar to that of the Poletta33 study, who said that for cleft lip and cleft palate high birth prevalence rates clusters were associated with high altitude above sea level, Native Amerindian ancestry, and low socioeconomic status; low birth prevalence rate clusters showed an association with African and Black ancestry. Advanced maternal age is a recognized risk factor for cleft palate only. Weinberg34 has suggested that similar occult lip defects are present in individuals affected with isolated cleft palate, and also that cleft palate and cleft lip plus cleft palate are etiologically distinct. These findings raise the possibility that some cleft palate cases may be misclassified.

Facial clefts are a heterogeneous group of easy-torecognize, nonfatal birth defects. Worldwide, it was reported as the most common congenital facial abnormality. A small proportion occur as a part of recognizable patterns of malformations or a genetic etiology, while epidemiologic data suggest that exogenous factors contribute to these conditions. Maternal factors, which have been studied for their influence on cleft risk, include smoking, alcohol consumption, medication use, environmental chemicals and nutritional factors, but none appear to explain a significant proportion of the population burden of these anomalies. Geographic differences in birth prevalence for these anomalies probably reflect differences in maternal life style and exposure to environmental causative factors.

Undescended testicle was the most prevalent birth defect in children between 1 and 5 years of age. Cryptorchidism is a common congenital anomaly that shows familial clustering and increased prevalence in first-degree relatives, suggesting that genetic factors contribute to the etiology. Nonsyndromic cryptorchidism is a common and complex disorder of unknown etiology with geographic and, perhaps, temporal variability. Although presumed to be multifactorial in etiology, few specific genetic or environmental factors have been clearly linked to this disease; there is evidence for multilocus genetic susceptibility.35

Cardiovascular system defects were by far the most common group of birth defects in our population. The prevalence rate for this kind of defect was very similar to rates previously published in comparable countries.36 However, it was possibly underdiagnosed in some pathologies due to lack of routine diagnostic systems, and because echocardiography and karyotype analysis are unavailable in the smaller provinces. It should be stressed that small cardiac defects close spontaneously in 30% to 50% of the cases. The most common cardiac birth defect was patent ductus arteriosus or patent arterial duct (PAD), defined as persistent patency in term infants older than 3 months. Isolated PAD is found worldwide in around 1 out of 2000 full-term infants. A higher prevalence is found in preterm infants, especially those of low birth weight.37 Persistence of the duct is associated with chromosomal aberrations, asphyxia at birth, birth at high altitude and congenital rubella. Occasional cases are associated with specific genetic defects (trisomy 21 and 18, and the Rubinstein- Taybi and CHARGE syndromes). Familial occurrence of PAD is uncommon and the usual mechanism of inheritance is considered to be polygenic, with a recurrence risk of 3%. Rare families with isolated PAD have been described in whom the inheritance appears to be dominant or recessive.37

Over the past few decades, there has been major progress in the understanding and management of cardiac birth defects, including identification of genetic causes for some conditions. Although early interventions have transformed the outcome for these patients, many have ongoing problems that require tertiary cardiac care in adult life. Furthermore, most adults require additional nontertiary care for issues such as pregnancy, noncardiac surgery, endocarditis and other problems. It is an important problem in public health, especially in relation to the costs of the hospitalization. These findings indicate a strong need to standardize both diagnostic and registration criteria for congenital heart malformations.

Our overall figure for Down’s syndrome was 3.8/10,000 births. Other published population-based rates for this syndrome are higher, as the ECLAMC study4 that found a BPR of 13.6/10,000 births. Down’s can be diagnosed relatively easily prior to birth by measuring alphafetoprotein, human chorionic gonadotropin and unconjugated estriol in fetal serum, detecting a thickened nuchal fold on fetal ultrasound, and by cytogenetic analysis. Thus, it is likely that many fetuses with Down’s were aborted electively and that variable abortion rates contribute to the variable prevalence of birth rates. In Ecuador, abortion by professional clinicians is allowed.

The prevalence of specific types of congenital anomalies at low and high altitudes in South America is higher in the high altitude lands than in the lowlands, especially for six types of birth defects: cleft lip, microtia, preauricular tag, branchial arch anomaly complex, constriction band complex, and anal atresias.38 Other authors have shown that altitude is associated with low birth weight and intrauterine growth retardation.39 These could be the most likely explanations40 for the unilateral cleft lip, the most frequent birth defect in Ecuador.

Limitations and strengths of this study

This report has at least five limitations in relation with the findings. First, this report does not determine severity within each type of birth defect; it analyzed the crude data without analyzing in depth each clinical situation. This limits the utility of these data for health-care planning, and justifies broader studies on this issue.

Second, this analysis could not separate children with isolated defects from those with more than one major defect or those with a recognized syndrome because the used registries do not emphasize these defects, and training in and knowledge of genetics of the health care providers, especially in primary care, is still very limited.

Third, it was not possible to determine how much of the variation is attributable to specific risk factors, and the prevalence of some of the defects is influenced by the sources of prenatal diagnoses used; this prevalence varies across hospitals and provinces in Ecuador. In some cases, the limitations are greater and clinical experience still remains the main criterion of diagnosis. The findings in this report represent a conservative estimate of the number of cases each year across the nation, but these data are only an estimate of congenital defects, which would be higher for some defects, if the data were based on systems that included prenatal and postnatal sources.

Fourth, these national estimates represent minimum estimates for the impact of these defects, because even those surveillance systems with active case-findings do not achieve 100% ascertainment.

Finally, some of the most common birth defects could be under represented and could not be included because identification of these conditions depends on referral patterns and access to and use of diagnostic procedures which vary from one hospital to another.

The creation of a National Registry of Birth Defects

This report documents the prevalence estimates for birth defects reported in the Hospital Discharge data. These estimates are important to 1) plan for health-care and education needs of the Ecuadorian population, 2) identify increased occurrence of birth defects in specific geographic regions, 3) serve as a reference point for assessment of provincial surveillance systems, 4) evaluate national public health interventions, 5) compare Ecuador prevalence estimates with those of other countries, and 6) help determine the appropriate allocation of resources for basic and public health research.

Hospital-based estimates help quantify the public health importance of these defects and can help improve the planning of services for affected children and their families; eg, the need for specific clinical specialists or multispecialty clinics. Children affected by certain birth defects could benefit from the availability of multispecialty clinics to address the coordination of multiple needs and continuity of ongoing care in a single setting. Because not all provinces have surveillance systems, the national prevalence estimates can be used by provinces to assess health services and special education programs, as well as to evaluate and improve their existing health programs and ensure that affected children are referred to the appropriate services.

Accurate national prevalence estimates of birth defects are essential because birth defects are one of the leading causes of infant mortality and a major contributor to childhood morbidity. Continued improvement can be achieved by a) enhancing completeness of ascertainment, b) increasing the consistency of methods among birth defects surveillance systems, and c) expanding the methods of data collection and analysis of birth defects for which reliable and valid estimates of national prevalence can be made.

In general, this study was limited to selected major birth defects, even though it is the first to provide population-based data on the prevalence rates within their class. The methods used for data collection and case generation are not enough to provide all the required information. Comparison with an independent source such as the birth medical history would be necessary to complete and improve the quality of the registries. Also, it would be important to begin registering defects in elective abortions, and in private medical offices where pathological prenatal identification is routine. As life can be sustained with many malformations, particularly with modern treatment and surgical correction, they are not detected by vital registration systems. Mortality data cannot provide reliable indications of birth prevalence of live birth malformations, and thus registries of such malformations are important.

Birth defects are a true public health problem that has been underestimated by health authorities in Ecuador. The emphasis by public health professionals on solving simpler problems such as diarrhea and respiratory infections has meant the neglect of this group of diseases, and birth defects have become almost hidden diseases. This study allows us to understand the urgent need to establish a National Registry of Birth Defects, involving different sources of information such as prenatal medical records, birth records, and postnatal medical records during the first year of life at an early stage, and surveys of cytogenetic prenatal diagnostic surveys and cytogenetics of therapeutic abortions.

The demonstrated prevalence and lack of documentation are sufficient reasons to initiate this registry. Of course, this new record will have to be combined with other measures such as a genetics education program for health providers, a public campaign to encourage healthcare workers to report cases of patients with genetic defects, and a specialized genetic counseling training program.

Disclosures

The authors declare no conflicts of interest. No funding was received for this work.

Contribution of authors

The conception, study design analysis and interpretation of data, drafting, critical revising and final approval of this manuscript were perfomed equally by FGA and RLP. Both authors are the guarantors of the paper.

Ethical approval

Not required as the study concerned retrospective analysis of a database.

References

  • 1.Penchaszadeh VB, Beiguelman B. Medical genetics services in Latin America: report of a meeting of experts. Rev Panam Salud Publica/Pan Am J Public Health. 1998;3:409–420. doi: 10.1590/s1020-49891998000600013. [DOI] [PubMed] [Google Scholar]
  • 2.Monitoring Birth Defects. [Accessed April 9, 2009.]. http://www.cdc.gov/ncbddd/bd/monitoring.htm.
  • 3.Castilla EE, López-Camelo JS. The surveillance of birth defects in South America: I, The search for time clusters: epidemics. Adv Mutagen Res. 1990;2:191–210. [Google Scholar]
  • 4.Montalvo G, Giron C, Camacho A, Martinez E, Toscano M, et al. Frecuencia de malformaciones congénitas en hospitales Ecuatorianos de la red ECLAMC. Período junio 2001-junio 2005. [Accessed Accessed April 9, 2009];Revista Cambios. 2005 5(9) [In Spanish] http://www.prenatal.tv/lecturas/ecuador/ECLAMC_Montalvo.pdf. [Google Scholar]
  • 5.Castilla EE, Sod R. The surveillance of birth defects in South America. II, The search for geographic clusters: endemics. Adv Mutagen Res. 1990;2:211–230. [Google Scholar]
  • 6.Cunha AJB. Orientação genética-clínica em medicina fetal. In: Isfer EV, Sanchez RC, Saito M, editors. Medicina fetal diagnóstico prénatal e conduta. Rio de Janeiro: Revinter; 1996. pp. 1–19. organizadores. [Google Scholar]
  • 7.Han A, Rotermann M, Fuller-Thomson E, Ray JG. Pre-conceptional folic acid supplement use according to maternal country of birth. J Obstet Gynaecol Can. 2009;31:222–226. doi: 10.1016/S1701-2163(16)34120-2. [DOI] [PubMed] [Google Scholar]
  • 8.González-Andrade F, López-Pulles R. Ecuador: Public Health Genomics. Public Health Genomics. 2009 doi: 10.1159/000249817. [DOI] [PubMed] [Google Scholar]
  • 9.United States. The CIA World Factbook. Washington, DC: Central Intelligence Agency; 2008. [Accessed April 9, 2009]. 1900s https://www.cia.gov/library/publications/the-world-factbook/geos/ec.html. [Google Scholar]
  • 10.Kold Jensen T. Children‘s health and environment: A review of evidence. A joint report from the European Environment Agency and the WHO Regional Office for Europe. Office for Official Publications of the European Community; 2002. Congenital malformations; pp. 116–126. [Google Scholar]
  • 11.INEC, Instituto Ecuatoriano de Estadísticas y Censos. Integrated System of Electronic Consults. National Vital Statistics; [Accessed April 9, 2009.]. http://www.inec.gov.ec/ [Google Scholar]
  • 12.González-Andrade F, Sánchez D, Martínez-Jarreta B. Sex-specific genetic admixture of Mestizos. Amerindian Kichwas and Blacks Afroamericans from Ecuador (South America) Human Biol. 2007;78:51–78. doi: 10.1353/hub.2007.0024. [DOI] [PubMed] [Google Scholar]
  • 13.Penchaszadeh V. Preventing congenital anomalies in developing countries. Community Genet. 2002;5:61–69. doi: 10.1159/000064632. [DOI] [PubMed] [Google Scholar]
  • 14.Canfield MA, Ramadhani TA, Shaw GM, et al. National Birth Defects Prevention Study. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2009;85:637–646. doi: 10.1002/bdra.20582. [DOI] [PubMed] [Google Scholar]
  • 15.Centers for Disease Control and Prevention. Update on Overall Prevalence of Major Birth Defects-Atlanta, Georgia, 1978–2005. Morb Mort Weekly Report. 2008;57:1–5. [PubMed] [Google Scholar]
  • 16.EUROCAT. Network of Anomaly Registers. [Accessed April 9, 2009.]. http://www.eurocat.ulster.ac.uk.
  • 17.Hobbs CA, Cleves MA, Simmons CJ. Genetic epidemiology and congenital malformations: From the chromosome to the crib. Arch Pediatr Adolesc Med. 2002;156:315–320. doi: 10.1001/archpedi.156.4.315. [DOI] [PubMed] [Google Scholar]
  • 18.Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. The National Birth Defects Prevention Study: Methods. Public Health Reports. 2001;116(Suppl 1):32–40. doi: 10.1093/phr/116.S1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lie RT, Wilcox AJ, Skjærven R. Survival and reproduction among males with birth defects and risk of recurrence in their children. JAMA. 2001;285:755–760. doi: 10.1001/jama.285.6.755. [DOI] [PubMed] [Google Scholar]
  • 20.Tilford JM, Robbins JM, Hobbs CA. Improving estimates of caregiver time cost and family burden associated with birth defects. Teratology. 2001;64(S1):37–41. doi: 10.1002/tera.1097. [DOI] [PubMed] [Google Scholar]
  • 21.Rasmussen SA, Erickson JD, Reef SE, Ross DS. Teratology: from science to birth defects prevention. Birth Defects Res A Clin Mol Teratol. 2009;85:82–92. doi: 10.1002/bdra.20506. [DOI] [PubMed] [Google Scholar]
  • 22.Mulholland C, Njoroge T, Mersereau P, Williams J. Comparison of guidelines available in the United States for diagnosis and management of diabetes before, during, and after pregnancy. J Womens Health (Larchmt) 2007;16:790–801. doi: 10.1089/jwh.2007.CDC7. [DOI] [PubMed] [Google Scholar]
  • 23.Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol. 2009;85:523–530. doi: 10.1002/bdra.20567. [DOI] [PubMed] [Google Scholar]
  • 24.Morice A, Ulloa-Gutierrez R, Avila-Agüero ML. Congenital rubella syndrome: progress and future challenges. Expert Rev Vaccines. 2009;8:323–331. doi: 10.1586/14760584.8.3.323. [DOI] [PubMed] [Google Scholar]
  • 25.Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol. 2006;22:214–226. doi: 10.1016/j.reprotox.2006.03.014. [DOI] [PubMed] [Google Scholar]
  • 26.Meaney FJ, Miller LA FASSNet Team. A comparison of fetal alcohol syndrome surveillance network and birth defects surveillance methodology in determining prevalence rates of fetal alcohol syndrome. Birth Defects Res A Clin Mol Teratol. 2003;67:819–822. doi: 10.1002/bdra.10122. [DOI] [PubMed] [Google Scholar]
  • 27.Floyd RL, Weber MK, Denny C, O’Connor MJ. Prevention of fetal alcohol spectrum disorders. Dev Disabil Res Rev. 2009;15:193–199. doi: 10.1002/ddrr.75. [DOI] [PubMed] [Google Scholar]
  • 28.MSP, Ministry of Public Health of Ecuador, National Epidemiological Surveillance System. [Accessed April 9, 2009.]. http://www.msp.gov.ec/index.phpoption=com_content&task=blogsection&id=21&Itemid=175.
  • 29.WHO. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007. Chapter XVII: Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) [Accessed April 9, 2009.]. http://www.who.int/classifications/apps/icd/icd10online/
  • 30.Vivar SC. Ecuador addresses cultural issues for pregnant women. Lancet. 2007;370:1302. doi: 10.1016/S0140-6736(07)61561-X. [DOI] [PubMed] [Google Scholar]
  • 31.Paz-Y-Miño C, Sánchez ME, Sarmiento I, Leone PE. Genetics and congenital malformations: interpretations, attitudes and practices in suburban communities and the shamans of Ecuador. Community Genet. 2006;9:268–273. doi: 10.1159/000094476. [DOI] [PubMed] [Google Scholar]
  • 32.Chedraui P. Pregnancy among young adolescents: trends, risk factors and maternal-perinatal outcome. J Perinat Med. 2008;36:256–259. doi: 10.1515/JPM.2008.047. [DOI] [PubMed] [Google Scholar]
  • 33.Poletta FA, Castilla EE, Orioli IM, López-Camelo JS. Regional analysis on the occurrence of oral clefts in South America. Am J Med Genet A. 2007;143A:3216–3227. doi: 10.1002/ajmg.a.32076. [DOI] [PubMed] [Google Scholar]
  • 34.Weinberg SM, Brandon CA, McHenry TH, et al. Rethinking isolated cleft palate: evidence of occult lip defects in a subset of cases. Am J Med Genet A. 2008;146A:1670–1675. doi: 10.1002/ajmg.a.32291. [DOI] [PubMed] [Google Scholar]
  • 35.Chacko JK, Barthold JS. Genetic and environmental contributors to cryptorchidism. Pediatr Endocrinol Rev. 2009;6:476–480. [PubMed] [Google Scholar]
  • 36.Baltaxe E, Zarante I. Prevalence of congenital heart disease in 44,985 newborns in Colombia. Arch Cardiol Mex. 2006;76:263–268. [PubMed] [Google Scholar]
  • 37.Forsey JT, Elmasry OA, Martin RP. Patent arterial duct. Orphanet J Rare Dis. 2009;4:17. doi: 10.1186/1750-1172-4-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Castilla EE, Lopez-Camelo JS, Campaña H. Altitude as a risk factor for congenital anomalies. Am J Med Genet. 1999;86:9–14. doi: 10.1002/(sici)1096-8628(19990903)86:1<9::aid-ajmg3>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  • 39.Webster WS, Howe AM, Abela D, Oakes DJ. The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin. Curr Pharm Des. 2006;12:1431–1448. doi: 10.2174/138161206776389868. [DOI] [PubMed] [Google Scholar]
  • 40.Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol. 2003;4:141–156. doi: 10.1089/152702903322022767. [DOI] [PubMed] [Google Scholar]
  • 41.International Clearinghouse For Birth Defects Surveillance and Research (ICBDSR) Annual Report with data for 2005. The ICBDSR Centre; Roma, Italy: 2007. [Google Scholar]

Articles from The Application of Clinical Genetics are provided here courtesy of Dove Press

RESOURCES